NxStage Medical, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 45 rows in 2016. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2016-12-20: Reporting owner TOWSE MATTHEW W; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2016-12-15: Reporting owner Swan Winifred L; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2016-11-28: Reporting owner Turk Joseph E Jr; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2016-11-25: Reporting owner Turk Joseph E Jr; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2016-12-20 | TOWSE MATTHEW W Officer (SVP and Chief Financial Office) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,300 42,730 owned after | $14.05 exercise price | 2016-12-20 | |
| 2016-12-15 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,000 47,542 owned after | $11.03 exercise price | 2016-12-16 | |
| 2016-11-28 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,669 12,880 owned after | $18.48 exercise price | 2016-11-29 | |
| 2016-11-25 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,000 46,897 owned after | $11.03 exercise price | 2016-11-29 | |
| 2016-11-25 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 12,723 owned after | $18.59 exercise price | 2016-11-29 | |
| 2016-11-22 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,000 50,542 owned after | $11.03 exercise price | 2016-11-22 | |
| 2016-11-21 | TOWSE MATTHEW W Officer (SVP and Chief Financial Office) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,300 47,030 owned after | $14.05 exercise price | 2016-11-21 | |
| 2016-11-14 | Mixer Jean K Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,579 0 owned after | $11.00 exercise price | 2016-11-16 | |
| 2016-11-02 | LEWIS EARL R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,272 0 owned after | $14.99 exercise price | 2016-11-04 | |
| 2016-11-02 | LEWIS EARL R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −18,196 0 owned after | $13.60 exercise price | 2016-11-04 | |
| 2016-08-04 | Giannini Daniel A Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,272 0 owned after | $14.99 exercise price | 2016-08-08 | |
| 2016-07-19 holding as of filing | Donigan Heyward R Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $21.73 exercise price | 2016-07-19 | ||
| 2016-07-15 | Donigan Heyward R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,366 14,366 owned after | $21.73 exercise price | 2016-07-19 | |
| 2016-06-24 | Peters James J Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,537 17,537 owned after | $19.03 exercise price | 2016-06-28 | |
| 2016-05-26 | Straube Barry M Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,854 15,854 owned after | $18.32 exercise price | 2016-05-27 | |
| 2016-05-26 | Mixer Jean K Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,854 15,854 owned after | $18.32 exercise price | 2016-05-27 | |
| 2016-05-26 | LEWIS EARL R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,854 15,854 owned after | $18.32 exercise price | 2016-05-27 | |
| 2016-05-26 | FUNARI ROBERT G Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,854 15,854 owned after | $18.32 exercise price | 2016-05-27 | |
| 2016-05-26 | Giannini Daniel A Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,854 15,854 owned after | $18.32 exercise price | 2016-05-27 | |
| 2016-05-26 | MOORE CRAIG W Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,854 15,854 owned after | $18.32 exercise price | 2016-05-27 | |
| 2016-05-26 | REID PERPER Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,854 15,854 owned after | $18.32 exercise price | 2016-05-27 | |
| 2016-05-25 | LEWIS EARL R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −14,000 0 owned after | $18.55 exercise price | 2016-05-27 | |
| 2016-05-25 | Giannini Daniel A Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −14,000 0 owned after | $18.55 exercise price | 2016-05-27 | |
| 2016-05-25 | MOORE CRAIG W Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −14,000 0 owned after | $18.55 exercise price | 2016-05-27 | |
| 2016-05-25 | REID PERPER Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,000 0 owned after | $18.55 exercise price | 2016-05-27 | |
| 2016-05-10 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,057 5,039 owned after | $9.96 exercise price | 2016-05-11 | |
| 2016-04-14 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −619 0 owned after | $9.96 exercise price | 2016-04-15 | |
| 2016-04-05 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 6,096 owned after | $9.96 exercise price | 2016-04-06 | |
| 2016-03-14 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −620 619 owned after | $9.96 exercise price | 2016-03-15 | |
| 2016-03-10 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 7,096 owned after | $9.96 exercise price | 2016-03-10 | |
| 2016-03-09 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +178,772 178,772 owned after | $15.58 exercise price | 2016-03-10 | |
| 2016-03-09 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +71,509 71,509 owned after | $15.58 exercise price | 2016-03-10 | |
| 2016-03-09 | Burbank Jeffrey H Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +268,159 268,159 owned after | $15.58 exercise price | 2016-03-10 | |
| 2016-03-09 | TOWSE MATTHEW W Officer (SVP and Chief Financial Office) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +89,386 89,386 owned after | $15.58 exercise price | 2016-03-10 | |
| 2016-03-09 | Brown Robert S. Officer (President, NxStage Kidney Care) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +71,509 71,509 owned after | $15.58 exercise price | 2016-03-10 | |
| 2016-02-24 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −992 0 owned after | $2.11 exercise price | 2016-02-25 | |
| 2016-02-16 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −620 1,239 owned after | $9.96 exercise price | 2016-02-18 | |
| 2016-02-12 | Burbank Jeffrey H Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 10,000 owned after | $2.11 exercise price | 2016-02-17 | |
| 2016-02-10 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −991 992 owned after | $2.11 exercise price | 2016-02-12 | |
| 2016-02-09 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 8,096 owned after | $9.96 exercise price | 2016-02-10 | |
| 2016-02-04 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −991 1,983 owned after | $2.11 exercise price | 2016-02-05 | |
| 2016-01-14 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −620 1,859 owned after | $9.96 exercise price | 2016-01-15 | |
| 2016-01-11 | TOWSE MATTHEW W Officer (SVP and Chief Financial Office) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,472 51,330 owned after | $14.05 exercise price | 2016-01-11 | |
| 2016-01-08 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,500 53,897 owned after | $11.03 exercise price | 2016-01-11 | |
| 2016-01-07 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,213 9,096 owned after | $9.96 exercise price | 2016-01-08 |